Drug Manufacturer Recalls 175,000 Bottles of Blood Pressure Medication Over Carcinogenic Impurities The Food and Drug Administration (FDA) announced a voluntary recall by Appco Pharma LLC of prazosin hydrochloride capsules, a medication used to treat hypertension and, off-label, for PTSD-related nightmares. The recall, initiated on March 31, 2026, was issued after testing revealed the presence of nitrosamine impurities in the product. Nitrosamines are classified by health agencies as probable human carcinogens. According to the FDA notice, the recall is ongoing and affects bottles distributed nationwide. The agency stated that the manufacturer initiated the action as a precautionary measure while…

Newswire

Features

The Latest